Advertisement
Advertisement
TEVA
Teva Pharmaceutical Industries Limited - ADR
37.34
USDSponsored
+0.53
+1.44%
Aug 21, 15:59 UTC -4
Closed
After-Market
37.31
-0.03
-0.08%
TEVA Earnings Reports
Positive Surprise Ratio
TEVA beat 15 of 31 last estimates.
48%
Next Report
Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$4.38B
/$0.74
Implied change from Q2 26 (Revenue/ EPS)
+5.70%
/+3600.00%
Implied change from Q3 25 (Revenue/ EPS)
-2.28%
/-5.13%
Teva Pharmaceutical Industries Limited - ADR earnings per share and revenue
On Jul 29, 2026, TEVA reported earnings of 0.02 USD per share (EPS) for Q2 26, missing the estimate of 0.25 USD, resulting in a -92.05% surprise. Revenue reached 4.14 billion, compared to an expected 4.13 billion, with a 0.34% difference. The market reacted with a +9.60% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of 0.74 USD, with revenue projected to reach 4.38 billion USD, implying an increase of 3600.00% EPS, and increase of 5.70% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BridgeBio Pharma, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.59
Actual
-$0.78
Surprise
-31.07%
Taysha Gene Therapies, Inc. Common Stock
Report Date
Aug 11, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.13
Surprise
-9.34%
FAQ
What were Teva Pharmaceutical Industries Limited - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Teva Pharmaceutical Industries Limited - ADR reported EPS of $0.02, missing estimates by -92.05%, and revenue of $4.14B, 0.34% above expectations.
How did the market react to Teva Pharmaceutical Industries Limited - ADR's Q2 2026 earnings?
The stock price moved up 9.6%, changed from $31.67 before the earnings release to $34.71 the day after.
When is Teva Pharmaceutical Industries Limited - ADR expected to report next?
The next earning report is scheduled for Nov 03, 2026.
What are the forecasts for Teva Pharmaceutical Industries Limited - ADR's next earnings report?
Based on 4
analysts, Teva Pharmaceutical Industries Limited - ADR is expected to report EPS of $0.74 and revenue of $4.38B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement